VIR - Company ID 0001706431
The table below shows Vir Biotechnology, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $68.56M | $74.20M | $86.18M | $1.62B | $1.10B | $76.37M |
| Cost of revenue | $26.00K | $845.00K | $2.77M | $146.32M | $65.86M | $0.00 |
| Gross profit | - | - | - | - | - | - |
| R&D | $455.97M | $506.50M | $579.72M | $474.65M | $448.01M | $302.41M |
Vir Biotechnology, Inc. reported annual revenue of $68.56M for fiscal year 2025. That is down 7.6% from $74.20M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $2.71M (FY 2017) to $68.56M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $92.07M |
| $119.03M |
| $174.44M |
| $161.76M |
| $160.79M |
| $70.94M |
| Operating income | -$479.33M | -$587.16M | -$684.30M | $833.07M | $420.75M | -$296.98M |
| Income tax | $217.00K | -$1.15M | -$13.08M | $238.44M | $21.22M | $54.00K |
| Net income | -$437.99M | -$521.96M | -$615.12M | $515.84M | $528.58M | -$298.67M |
| EPS (diluted) | -$3.16 | -$3.83 | -$4.59 | $3.83 | $3.96 | -$2.51 |